1. Brazil’s Hypera to launch generic Ozempic in 2026
  2. TikTok’s ADHD misinformation crisis: Study exposes dangers of viral claims
  3. Lone wolf fallacy: How sigma masculinity became internet’s toxic inside joke
  4. AstraZeneca to invest $2.5 Billion in Beijing R&D hub, expands China presence
  5. Semaglutide may combat Alzheimer’s by reducing brain inflammation:Study
  6. Scientists unveil PINK1 protein structure, paving way for Parkinson’s Disease therapies
  7. Key protein ArfGAP2 identified as driver of autoimmune diseases
  8. Study uncovers protein’s dual role in sepsis, offering new treatment hope
  9. Abrupt cessation of US funds could lead to 3 million HIV-related deaths: WHO
  10. Celon Pharma’s pill shows promise in reducing dyskinesia in Parkinson’s trial
  11. AstraZeneca acquires EsoBiotec for $1billion in a bid to push its cell therapy agenda
  12. Eneboparatide succeeds in Phase III trial for chronic hypoparathyroidism
  13. MIT’s 40Hz gamma stimulation shows promise in slowing Alzheimer’s progression
  14. Australian man becomes world’s first to leave hospital with titanium heart
  15. UN narcotics agency places 6 new substances under international control
Nova Nordisk's Ozempic has changed he weight loss landscape

Brazil’s Hypera to launch generic Ozempic in 2026

  • March 24, 2025
depression

TikTok’s ADHD misinformation crisis: Study exposes dangers of viral claims

  • March 22, 2025
Being popular means being louder. An actor, musician, sportsperson or politician opening up about his or her mental health is better heard than an ordinary individual.

Lone wolf fallacy: How sigma masculinity became internet’s toxic inside joke

  • March 22, 2025
AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish drugmaker.

AstraZeneca to invest $2.5 Billion in Beijing R&D hub, expands China presence

  • March 21, 2025
US adults who will develop dementia every year will rise to one million in 2060 from 514,000 in 2020, according to a study published in Nature Medicine.
Health

Semaglutide may combat Alzheimer’s by reducing brain inflammation:Study

Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.
Health Research

Scientists unveil PINK1 protein structure, paving way for Parkinson’s Disease therapies

Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.
Health Research

Key protein ArfGAP2 identified as driver of autoimmune diseases

Eight people have died in Rwanda due to Marburg virus disease and 26 others were confirmed to be infected by the illness — the first such in the eastern-central African nation.
Drugs Research

Study uncovers protein’s dual role in sepsis, offering new treatment hope

The UNICEF and the private-public partnership Gavi Vaccine Alliance will roll out its malaria vaccine for the first time in nine African countries to fight one of the deadliest diseases in the continent, according to the WHO.
Drugs Health

Abrupt cessation of US funds could lead to 3 million HIV-related deaths: WHO

Research

Research
depression
Health Research

TikTok’s ADHD misinformation crisis: Study exposes dangers of

Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.
Health, Research

Scientists unveil PINK1 protein structure, paving way

  • March 20, 2025
Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.
Health, Research

Key protein ArfGAP2 identified as driver of

  • March 20, 2025
Eight people have died in Rwanda due to Marburg virus disease and 26 others were confirmed to be infected by the illness — the first such in the eastern-central African nation.
Drugs, Research

Study uncovers protein’s dual role in sepsis,

  • March 18, 2025
Drugs, Research

Celon Pharma’s pill shows promise in reducing

  • March 17, 2025
Grey matter in the human brain may be linked to the start of adolescent smoking and nicotine addiction — a study that may have implications for prevention and treatment.
Health, Research

MIT’s 40Hz gamma stimulation shows promise in

  • March 15, 2025
Intensive diet and lifestyle changes may forestall a cognitive decline in Alzheimer’s disease and make progress for patients during early stages, a study finds.
Health, Research

Parkinson’s Disease cases to hit 25 million

  • March 10, 2025

Opinion

Being popular means being louder. An actor, musician, sportsperson or politician opening up about his or her mental health is better heard than an ordinary individual.
Opinion

Lone wolf fallacy: How sigma masculinity became internet’s toxic inside joke

In ancient Greece, King Midas wished for the golden touch, believing that unlimited wealth would bring him ultimate happiness. However, his dream quickly turned into a nightmare when his food—and even his beloved daughter—turned to gold.  Midas became trapped by his irrational desire, blinded by the allure of wealth without considering its consequences.
Health, Opinion, Research

Curbing the King Midas’ golden touch in you during modern times

In ancient Greece, King Midas wished for the golden touch, believing that unlimited wealth would bring him ultimate happiness. However, his dream quickly turned into a nightmare when his food—and even his beloved daughter—turned to gold. Midas became trapped by his irrational desire, blinded by the allure of wealth without considering its consequences.
Opinion

Chayamukhi: The Indian story of a mirror that reflects true human desire

broken heart love stories maybe eulogised but carry some difficult psychological traits
Opinion

Exploring the complexities of tragic characters in doomed love stories

Get The Best Stories
into Your inbox!

Subscription 03

Be the first to know about our exciting News from your favorite products